Show
Sort by
-
Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis
-
- Journal Article
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients
-
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets
-
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients
-
Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients